Summary: Creative Biolabs Sensitive Immunogenicity Assessment Technology (SIAT) is a highly sensitive and unique assay in accordance with specific FDA and EMA guidelines. SIAT includes in vivo, ex vivo, in vitro and in silico methods, which are effective in a wide range of applications including quantitation of biological drugs, determination of anti-drug antibodies (ADAs) and measurement of pharmacokinetic/pharmacodynamic markers. https://www.creative-biolabs.com/Immunogenicity-Assessment.html